Sherry is Chief Financial Officer at Xenon Pharmaceuticals (XENE), a Nasdaq-traded company with a market cap of approximately $2.5B USD, headquartered in Vancouver and one of British Columbia’s most valuable public companies. Sherry’s career with Xenon took off when she played a key role in the company’s 2014 IPO. Since becoming CFO of Xenon in 2021, Sherry has raised over $630 million USD in equity capital, Xenon’s stock price has more than doubled, and she’s overseen significant employee growth with operating responsibilities for finance, legal, IT, facilities, corporate communications and investor relations. Sherry started her career at KPMG LLP, where she provided professional services to publicly-traded companies across various industries including in the life sciences sector. Ms. Aulin holds a BCom from the University of British Columbia and is a Chartered Professional Accountant, Chartered Accountant.